Form 4: Medpace Executive Sells 18,000 Shares in Pre-Planned Trade

A Medpace Holdings, Inc. executive sold 18,000 shares of common stock for $605 per share on November 11, 2025, as part of a pre-arranged plan.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), reported the sale of 18,000 shares of common stock.
• The transaction occurred on November 11, 2025, at a price of $605 per share.
• The total value of the shares sold was $10,890,000 (18,000 shares * $605/share).
• Following this transaction, Ms. Burwig beneficially owns 47,500 shares of Medpace Holdings, Inc. common stock.
• The sale was executed pursuant to a limit order placed by the reporting person during an open window period and was made under a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider stock sale, which is a routine disclosure and does not inherently reflect on the company's operational performance or future prospects. The transaction was executed under a Rule 10b5-1 plan, indicating it was scheduled in advance.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is specific to Medpace Holdings, Inc. and its executive, Susan E. Burwig. It does not directly provide insights into broader industry trends or competitor activities, beyond being a routine disclosure of executive stock ownership changes common across publicly traded companies.

Stakeholder Impact

• Shareholders may view the sale of a significant number of shares by an executive as a potential signal, although the Rule 10b5-1 plan mitigates immediate negative interpretations.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The sale of 18,000 shares by an executive, while significant in value, was executed pursuant to a pre-arranged Rule 10b5-1 plan. Such plans are often established for personal financial planning and do not necessarily indicate a negative outlook on the company's future. Investors should monitor future insider activity and company performance rather than reacting solely to this pre-planned transaction.

Keywords

Medpace Holdings, MEDP, Insider Sale, Form 4, Executive Stock Sale, Susan E. Burwig, Rule 10b5-1